3 completed, 3 terminated. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Terminated 3 |
Follow padeliporfin: new trials by email Literature Review of padeliporfin trials Research Report on padeliporfin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer. TOOKAD Soluble 4 mg/kg - Localized Prostate Cancer | Phase 2 | Completed | Steba Biotech S.A. | 50 | 2017-10-02 | 2026-09-10 |
| Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD STAKEL - Macular Degeneration, Choroidal Neovascularization | Phase 2 | Terminated | Steba Biotech S.A. | 10 | 2010-06-01 | 2018-09-17 |
| Study Using WST11 in Patients With Localized Prostate Cancer WST11 - Prostate Cancer | Phase 2 | Completed | Steba Biotech S.A. | 86 | 2009-09-01 | 2015-04-28 |
| Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma WST11 - Cholangiocarcinoma | Phase 2 | Terminated | Steba Biotech S.A. | 8 | 2009-09-01 | 2016-04-18 |
| Study Using WST11 in Patients With Obstructing Endobronchial Non-Small Cell Lung Cancer WST11 - Non-Small Cell Lung Cancer | Phase 2 | Terminated | Steba Biotech S.A. | 3 | 2009-09-01 | 2015-04-28 |
| Study of WST11 in Patients With Localized Prostate Cancer WST11 - Prostate Cancer | Phase 2 | Completed | Steba Biotech S.A. | 42 | 2008-09-01 | 2016-04-19 |
Carcinoma (3) · Genital Neoplasms, Male (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Prostatic Diseases (2) · Prostatic Neoplasms (2) · Urogenital Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1) · Cholangiocarcinoma (1) · Choroidal Neovascularization (1) · Genital Diseases (1) · Genital Diseases, Male (1) · Lung Neoplasms (1) · Macular Degeneration (1)
France (5) · United Kingdom (2) · United States (2) · Canada (1) · Netherlands (1)
Adrienne Scott, Doctor (1) · Emmanuel Ben Soussan, MD (1) · Francine Behar Cohen, Professor (1) · John Wells, Professor (1) · Jonathan Coleman, MD (1) · Mark Emberton, Professor (1) · Michel Leroy, MD (1) · Michel de Wildt, MD (1) · Neil Bressler, Professor (1)
PMID 25614256, PMID 25712310, PMID 25786708, PMID 21296274, PMID 24028764, PMID 24841929